Cat: IPD-X41469

Recombinant Human cytomegalovirus A143V,V207A Protein ,His

  • Price
  • Size
  • Number

    Order now. For delivery time, please consult customer service

  • Pre-sale guidance and worry-free after-sale service
  • Quality assurance for cold chain transportation

Analytical Data

  • 基因名

    A143V,V207A

  • Application

    SPRMSTBLIITCELISA细胞实验药物筛选

  • 别名

    (Protease precursor)(pPR)

  • 种属

    Human cytomegalovirus

  • 表达系统

    E. coli

  • 标签

    N- His

  • 纯度

    Greater than 90% as determined by SDS-PAGE.

  • 蛋白编号

    P16753

  • 表达区间

    1-256aa(A143V,V207A)

  • 分子量

    34.0 kDa

  • 内毒素

    < 1.0 EU per μg protein as determined by the LAL method.

  • 性状

    Freeze-dried powder

  • 缓冲液

    PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.

  • 复溶方法

    Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.

  • 个性化定制

    点位突变 标签定制 buffer定制 全长蛋白定制

  • 稳定性测试

    The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.

  • 保存条件 & 期限

    Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.

  • 运输条件

    In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.

Quality inspection process

Related Products

Protein Description

The study of recombinant proteins A143V and V207A has gained significance within the field of structural biology and biochemistry due to their implications in understanding protein stability and functionality. These specific mutations are often investigated in the context of various diseases, particularly neurodegenerative disorders, where protein misfolding and aggregation play crucial roles. By introducing these mutations into model proteins, researchers aim to elucidate the effects on folding pathways, thermodynamic stability, and interaction with other biomolecules. The A143V variant, for instance, has been studied for its impact on the conformational dynamics of proteins, potentially altering their biological activity and interaction networks. Similarly, V207A has been explored for its effects on oligomerization processes, which are critical in the formation of functional protein complexes. Understanding these mutations at a molecular level not only provides insights into the basic principles of protein behavior but also holds potential for therapeutic applications. Through techniques like X-ray crystallography and nuclear magnetic resonance (NMR) spectroscopy, researchers can obtain detailed structural information that contributes to the design of targeted interventions to mitigate pathogenic effects stemming from protein misfolding. Overall, the investigation of A143V and V207A serves as a pivotal aspect of the broader research endeavor to decode the complexities of protein biology and its associations with human diseases.

客服热线

027-8586 6806

E-mail

sales@ipodix.cn

人工客服①

汪经理

18007124176


加微信咨询

人工客服②

简经理

18164034885


加微信咨询
IPODIX North America (HQ)
Proteintech Group, Inc
5500 Pearl Street, Suite 400
Rosemont, IL 60018, USA
1-888-478-4522
proteintech@ptglab.com
IPODIX North America (HQ)
Proteintech Group, Inc
5500 Pearl Street, Suite 400
Rosemont, IL 60018, USA
1-888-478-4522
proteintech@ptglab.com
IPODIX North America (HQ)
Proteintech Group, Inc
5500 Pearl Street, Suite 400
Rosemont, IL 60018, USA
1-888-478-4522
proteintech@ptglab.com
  • 30000+

    Recombinant

  • 100+

    Researcher

  • 100+

    Countries Served

  • ISO

    Certified Quality

Committed to Quality
Driven by Innovation

Learn More About US